TY - JOUR
T1 - Hypoxia-inducible factor 1α induces corticosteroid-insensitive inflammation via reduction of histone deacetylase-2 transcription
AU - Charron, C.E.
AU - Chou, P.-C.
AU - Coutts, D.J.C.
AU - Kumar, V.
AU - To, M.
AU - Akashi, K.
AU - Pinhu, L.
AU - Griffiths, M.
AU - Adcock, I.M.
AU - Barnes, P.J.
AU - Ito, K.
N1 - 引用次數:25
Export Date: 13 September 2018
CODEN: JBCHA
通訊地址: Charron, C.E.; Section of Airway Disease, National Heart and Lung Institute, Imperial College London, London SW3 6LY, United Kingdom; 電子郵件: [email protected]
化學物質/CAS: dexamethasone, 50-02-2; interleukin 8, 114308-91-7; Basic Helix-Loop-Helix Transcription Factors; Dexamethasone, 50-02-2; Glucocorticoids; HDAC2 protein, human, 3.5.1.98; HIF1A protein, human; Histone Deacetylase 2, 3.5.1.98; Hypoxia-Inducible Factor 1, alpha Subunit; IL8 protein, human; Interleukin-1beta; Interleukin-8; RNA, Messenger; endothelial PAS domain-containing protein 1
參考文獻: Lee, K.A., Roth, R.A., LaPres, J.J., (2007) Pharmacol. Ther, 113, pp. 229-246; Wenger, R.H., Stiehl, D.P., Camenisch, G., (2005) Sci. STKE, 2005, pp. re12; Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Schumacker, P.T., (2005) Cell Metab, 1, pp. 401-408; Blouin, C.C., Pagé, E.L., Soucy, G.M., Richard, D.E., (2004) Blood, 103, pp. 1124-1130; Thornton, R.D., Lane, P., Borghaei, R.C., Pease, E.A., Caro, J., Mochan, E., (2000) Biochem. J, 350, pp. 307-312; Tacchini, L., De Ponti, C., Matteucci, E., Follis, R., Desiderio, M.A., (2004) Carcinogenesis, 25, pp. 2089-2100; Barnes, P.J., Adcock, I.M., Ito, K., (2005) Eur. Respir. J, 25, pp. 552-563; Ito, K., Barnes, P.J., Adcock, I.M., (2000) Mol. Cell. Biol, 20, pp. 6891-6903; Ito, K., Caramori, G., Lim, S., Oates, T., Chung, K.F., Barnes, P.J., Adcock, I.M., (2002) Am. J. Respir. Crit. Care Med, 166, pp. 392-396; Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J., Adcock, I.M., (2006) J. Exp. Med, 203, pp. 7-13; Ito, K., Ito, M., Elliott, W.M., Cosio, B., Caramori, G., Kon, O.M., Barczyk, A., Barnes, P.J., (2005) N. Engl. J. Med, 352, pp. 1967-1976; Smith, S.J., Fenwick, P.S., Nicholson, A.G., Kirschenbaum, F., Finney- Hayward, T.K., Higgins, L.S., Giembycz, M.A., Donnelly, L.E., (2006) Br. J. Pharmacol, 149, pp. 393-404; McDonough, M.A., Li, V., Flashman, E., Chowdhury, R., Mohr, C., Liénard, B.M., Zondlo, J., Schofield, C.J., (2006) Proc. Natl. Acad. Sci. U.S.A, 103, pp. 9814-9819; Kim, K.S., Rajagopal, V., Gonsalves, C., Johnson, C., Kalra, V.K., (2006) J. Immunol, 177, pp. 7211-7224; Sengupta, N., Seto, E., (2004) J. Cell. Biochem, 93, pp. 57-67; Komarova, E.A., Krivokrysenko, V., Wang, K., Neznanov, N., Chernov, M.V., Komarov, P.G., Brennan, M.L., Gudkov, A.V., (2005) FASEB J, 19, pp. 1030-1032; Mejlvang, J., Kriajevska, M., Vandewalle, C., Chernova, T., Sayan, A.E., Berx, G., Mellon, J.K., Tulchinsky, E., (2007) Mol. Biol. Cell, 18, pp. 4615-4624; Ebert, B.L., Bunn, H.F., (1998) Mol. Cell. Biol, 18, pp. 4089-4096; Wyrwicz, L.S., Gaj, P., Hoffmann, M., Rychlewski, L., Ostrowski, J., (2007) Acta Biochim. Pol, 54, pp. 89-98; Kim, M.S., Kwon, H.J., Lee, Y.M., Baek, J.H., Jang, J.E., Lee, S.W., Moon, E.J., Kim, K.W., (2001) Nat. Med, 7, pp. 437-443; Pluemsampant, S., Safronova, O.S., Nakahama, K., Morita, I., (2008) Int. J. Cancer, 122, pp. 333-341; Kato, H., Tamamizu-Kato, S., Shibasaki, F., (2004) J. Biol. Chem, 279, pp. 41966-41974; Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., Brüne, B., (2003) Mol. Biol. Cell, 14, pp. 3470-3481; Brindicci, C., Ito, K., Resta, O., Pride, N.B., Barnes, P.J., Kharitonov, S.A., (2005) Eur. Respir. J, 26, pp. 52-59; Nagy, G., Clark, J.M., Buzas, E., Gorman, C., Pasztoi, M., Koncz, A., Falus, A., Cope, A.P., (2008) Immunol. Lett, 118, pp. 55-58; Lim, K.H., Ancrile, B.B., Kashatus, D.F., Counter, C.M., (2008) Nature, 452, pp. 646-649; Gerald, D., Berra, E., Frapart, Y.M., Chan, D.A., Giaccia, A.J., Mansuy, D., Pouysségur, J., Mechta-Grigoriou, F., (2004) Cell, 118, pp. 781-794; Bonello, S., Zähringer, C., BelAiba, R.S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T., Görlach, A., (2007) Arterioscler. Thromb. Vasc. Biol, 27, pp. 755-761; Barnes, P.J., (2007) PLoS Med, 4, pp. e112; Filippin, L.I., Vercelino, R., Marroni, N.P., Xavier, R.M., (2008) Clin. Exp. Immunol, 152, pp. 415-422
PY - 2009/12/25
Y1 - 2009/12/25
N2 - Corticosteroids are potent anti-inflammatory agents, but corticosteroid insensitivity is a major barrier for the treatment of some chronic inflammatory diseases. Here, we show that hypoxia induces corticosteroid-insensitive inflammation via reduced transcription of histone deacetylase-2 (HDAC2) in lung epithelial and macrophage cells. HDAC2 mRNA and protein expression was reduced under hypoxic conditions (1% O2). Hypoxia enhanced interleukin-1β-induced interleukin-8 (CXCL8) production in A549 cells and decreased the ability of dexamethasone to suppress the CXCL8 production. Deletion or point mutation studies revealed that binding of the transcription factor hypoxia-inducible factor (HIF) 1a to a HIF response element at position 320, but not HIF-1b or HIF-2a, results in reduced polymerase II binding at the site, leading to reduced promoter activity ofHDAC2.Our results suggest that activation of HIF-1α by hypoxia decreases HDAC2 levels, resulting in amplified inflammation and corticosteroid resistance. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
AB - Corticosteroids are potent anti-inflammatory agents, but corticosteroid insensitivity is a major barrier for the treatment of some chronic inflammatory diseases. Here, we show that hypoxia induces corticosteroid-insensitive inflammation via reduced transcription of histone deacetylase-2 (HDAC2) in lung epithelial and macrophage cells. HDAC2 mRNA and protein expression was reduced under hypoxic conditions (1% O2). Hypoxia enhanced interleukin-1β-induced interleukin-8 (CXCL8) production in A549 cells and decreased the ability of dexamethasone to suppress the CXCL8 production. Deletion or point mutation studies revealed that binding of the transcription factor hypoxia-inducible factor (HIF) 1a to a HIF response element at position 320, but not HIF-1b or HIF-2a, results in reduced polymerase II binding at the site, leading to reduced promoter activity ofHDAC2.Our results suggest that activation of HIF-1α by hypoxia decreases HDAC2 levels, resulting in amplified inflammation and corticosteroid resistance. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
KW - A549 cells
KW - Anti-inflammatory agents
KW - Chronic inflammatory disease
KW - Dexamethasones
KW - Histone deacetylases
KW - Hypoxia-inducible factor 1
KW - Hypoxia-inducible factors
KW - Hypoxic condition
KW - Interleukin-1
KW - Interleukin-8
KW - Macrophage cells
KW - Point mutations
KW - Polymerase II
KW - Promoter activities
KW - Protein expressions
KW - Response elements
KW - Pathology
KW - Transcription
KW - Transcription factors
KW - Drug products
KW - corticosteroid
KW - dexamethasone
KW - DNA directed DNA polymerase alpha
KW - histone deacetylase 2
KW - hypoxia inducible factor 1alpha
KW - hypoxia inducible factor 1beta
KW - hypoxia inducible factor 2alpha
KW - interleukin 8
KW - messenger RNA
KW - article
KW - binding site
KW - cell strain
KW - controlled study
KW - cytokine production
KW - drug resistance
KW - gene deletion
KW - gene expression
KW - gene function
KW - human
KW - human cell
KW - hypoxia
KW - inflammation
KW - lung alveolus epithelium
KW - macrophage
KW - mutational analysis
KW - point mutation
KW - priority journal
KW - promoter region
KW - protein binding
KW - protein degradation
KW - protein expression
KW - transcription initiation
KW - transcription regulation
KW - Basic Helix-Loop-Helix Transcription Factors
KW - Cell Hypoxia
KW - Dexamethasone
KW - Drug Resistance
KW - Gene Expression Regulation, Enzymologic
KW - Glucocorticoids
KW - Histone Deacetylase 2
KW - Humans
KW - Hypoxia-Inducible Factor 1, alpha Subunit
KW - Inflammation
KW - Interleukin-1beta
KW - Macrophages
KW - Point Mutation
KW - Respiratory Mucosa
KW - Response Elements
KW - RNA, Messenger
KW - U937 Cells
UR - https://www.scopus.com/results/citedbyresults.uri?sort=plf-f&cite=2-s2.0-73649086907&src=s&imp=t&sid=6244bfc37402fd2096bc74b39b323142&sot=cite&sdt=a&sl=0&origin=recordpage&editSaveSearch=&txGid=4298f7415ccdb3506d3be716645af62d
U2 - 10.1074/jbc.M109.025387
DO - 10.1074/jbc.M109.025387
M3 - Article
SN - 0021-9258
VL - 284
SP - 36047
EP - 36054
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 52
ER -